The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß-catenin signaling - Krug, Sebastian; Roth, Laura; Hämmerle, Monika; Rosendahl, Jonas; Kleeff, Jörg H.; Michl, Patrick (Cancer reports, 2022)
Online veröffentlich am 26. Juli 2021